KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Retained Earnings (2016 - 2025)

Johnson & Johnson's Retained Earnings history spans 17 years, with the latest figure at -$14.9 billion for Q4 2025.

  • For Q4 2025, Retained Earnings fell 27.16% year-over-year to -$14.9 billion; the TTM value through Dec 2025 reached -$14.9 billion, down 27.16%, while the annual FY2025 figure was -$14.9 billion, 27.16% down from the prior year.
  • Retained Earnings for Q4 2025 was -$14.9 billion at Johnson & Johnson, up from -$15.2 billion in the prior quarter.
  • Across five years, Retained Earnings topped out at $165.4 billion in Q2 2025 and bottomed at -$15.3 billion in Q4 2022.
  • The 5-year median for Retained Earnings is $116.5 billion (2021), against an average of $73.7 billion.
  • The largest annual shift saw Retained Earnings tumbled 112.63% in 2022 before it soared 1610.35% in 2025.
  • A 5-year view of Retained Earnings shows it stood at $121.1 billion in 2021, then crashed by 112.63% to -$15.3 billion in 2022, then soared by 1106.04% to $153.8 billion in 2023, then tumbled by 107.63% to -$11.7 billion in 2024, then decreased by 27.16% to -$14.9 billion in 2025.
  • Per Business Quant, the three most recent readings for JNJ's Retained Earnings are -$14.9 billion (Q4 2025), -$15.2 billion (Q3 2025), and $165.4 billion (Q2 2025).